Azat Chinaliyev

Dr. Azat Chinaliyev

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
YSYuliya Semenova
Yuliya Semenova
ZBZhandos Burkitbayev
Zhandos Burkitbayev
SSSanzhar Shalekenov
Sanzhar Shalekenov
OSOxana Shatkovskaya
Oxana Shatkovskaya
GDGauhar Dunenova
Gauhar Dunenova
LPLyudmila Pivina
Lyudmila Pivina
Breast cancer (BC) is the most common cancer in Kazakhstan, and a population-based breast cancer screening program was introduced in 2008, initially targeting women aged 50–60 years. It was subsequently expanded in 2018 to include women aged 40–70 years. This study evaluates the national BC screening program from its introduction in 2008 onward, focusing on program outputs, outcomes, and associated expenditures. Several administrative datasets and official sources were analyzed, including the legislative acts database, analytical reports on cancer screening programs, and cancer reporting forms. Trends in key indicators were summarized using the average annual percent change (AAPC). From the program’s inception, the absolute number of women screened increased steadily, with an AAPC of 6.23%. In contrast, the proportion of eligible women covered by screening declined over time, particularly following the expansion of the target age groups in 2018. Stage I BC detected through screening accounted for only about 50% of all stage I BC cases diagnosed nationwide, while the contribution of screening to stage II cancers was below 30%. Neither the introduction nor the subsequent expansion of the BC screening program was associated with statistically significant immediate or trend changes in national BC incidence or mortality rates. These findings may inform evidence-based discussions on potential refinements to BC screening policy and practice in Kazakhstan.

1 January 2019 in HPB
Verified
Journal Article
Closed access
ASAkhmet Seidakhmetov
Akhmet Seidakhmetov
SZSerik Zharikov
Serik Zharikov
ACAzat Chinaliyev
Azat Chinaliyev

14 January 2026 in Oncology, Nuclear Medicine and Transplantology
Verified
Journal Article
Open access
PDF file
ZBZhandos Burkitbayev
Zhandos Burkitbayev
ACAzat Chinaliyev
Azat Chinaliyev
DKDidar Khassenov
Didar Khassenov
KBKanat Batyrbekov
Kanat Batyrbekov
AKAsset Kenzhin
Asset Kenzhin
SYShaimerden Yedige
Shaimerden Yedige
Biliary strictures represent one of the most common complications after liver transplantation, occurring in 10-30% of recipients and significantly affecting patient quality of life and graft function. Combined hybrid approaches are increasingly widespread in contemporary practice. Objective: To present a case series of successful application of combined methods for biliary stricture management in patients after liver transplantation and to analyze the efficacy and safety of these approaches. Methods: A prospective observational study of three female patients (median age 57.0±7.8 years) after orthotopic liver transplantation with biliary strictures was conducted. All underwent a combined procedure using the rendezvous technique, integrating percutaneous transhepatic and endoscopic approaches with biliary stent placement. Results: Technical success was achieved in 100% of cases (3/3). Clinical success with bilirubin reduction >50% was registered in all patients (3/3, 100%). Total bilirubin decreased from 71.3±22.8 μmol/L to 58.2±18.5 μmol/L by day 7 and to 32.4±8.6 μmol/L by day 30. No serious complications were registered (0/3, 0%). Mean hospitalization was 5.3±1.5 days (range 4-7 days). Mean procedure duration was 85±15 minutes. Conclusion: The combined method demonstrated high technical feasibility (100%), clinical efficacy (100%), and a favorable safety profile with no serious complications, showing particular effectiveness in recurrent strictures. This approach can be considered as a promising alternative to isolated interventions in treating complex anastomotic biliary strictures.

9 September 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
GCGulinur Chinaliyeva
Gulinur Chinaliyeva
ACAzat Chinaliyev
Azat Chinaliyev
ZAZhanna Amirbekova
Zhanna Amirbekova
ASAmankeldi A. Salybekov
Amankeldi A. Salybekov
ASAida Shakirova
Aida Shakirova
NDNino Dznelashvili
Nino Dznelashvili
Background/Objectives: Molecular classification has reshaped risk assessment in endometrial cancer (EC), but the strength and clinical applicability of the evidence vary across molecular subgroups, assay platforms, patient populations, and treatment settings. This systematic review critically evaluated the prognostic and predictive value of TCGA-derived classifiers, additional biomarkers, multiple-classifier tumors, and molecularly informed therapeutic strategies. Methods: A protocol was developed a priori but was not prospectively registered. PubMed/MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library were searched for primary studies published from January 2013 through June 2026. Clinical guidelines were used only to provide clinical context and were not included in the formal evidence set. Because of substantial methodological heterogeneity, findings were synthesized narratively by study design and clinical question. Risk of bias was assessed using QUADAS-2, the Newcastle–Ottawa Scale, and RoB 2. Results: Seventy-four studies involving approximately 42,000 patients were included. POLE-mutated tumors showed the most favorable outcomes in most cohorts, whereas p53-abnormal tumors, defined by abnormal immunohistochemical patterns, generally had the poorest prognosis. Mismatch repair deficiency identified by immunohistochemistry and microsatellite instability-high status identified by PCR- or NGS-based testing were highly related but analytically distinct biomarkers and were not treated as exact synonyms. The NSMP group remained heterogeneous; integrated assessment of estrogen/progesterone receptor expression, CTNNB1, L1CAM, ARID1A, and chromosome 1q alterations may improve risk discrimination, although most of these markers remain investigational. In multiple-classifier tumors, available data support a practical hierarchy in which a pathogenic POLE mutation generally takes precedence, followed by MMR deficiency and then p53 abnormality. Across studies, molecular classification usually added prognostic information to clinicopathologic assessment, but the magnitude of benefit varied, and no overall certainty rating was assigned. Conclusions: Molecular classification is incorporated into contemporary guidelines and can support prognostic assessment and treatment selection when interpreted together with stage, histology, and other clinicopathologic factors. The strongest current clinical utility relates to POLE, MMR/MSI, p53 immunohistochemistry, and HER2 in selected settings; additional NSMP and multi-omics biomarkers require prospective validation, assay standardization, and demonstration of clinical utility before routine adoption.

1 January 2026 in Actual Problems of Theoretical and Clinical Medicine
Verified
Journal Article
Closed access
DKDidar Khassenov
Didar Khassenov
SBS. Bakhtiyar
S. Bakhtiyar
SSS. S. Saparbayev
S. S. Saparbayev
TST. A. Sultanaliyev
T. A. Sultanaliyev
ACAzat Chinaliyev
Azat Chinaliyev
GOGaliya Orazova
Galiya Orazova
Relevance. Chronic limb-threatening ischemia is the most severe manifestation of peripheral artery disease, carrying high rates of amputation and mortality. Structured patient education programs have demonstrated benefit in other chronic diseases, yet remain largely unevaluated in peripheral artery disease, particularly chronic limb-threatening ischemia. Objective. To evaluate the effectiveness of a structured multimodal educational program (CLTI School) compared with standard care on clinical outcomes and quality of life in patients with peripheral artery disease. Materials and Methods. Parallel-group randomized controlled trial conducted in Astana, Kazakhstan. A total of 184 patients with peripheral artery disease (Rutherford categories 2-5) were randomized 1:1 and followed for 12 months. The program comprised eight vascular surgeon-led group sessions, a digital platform, peer support groups, and smoking cessation counseling. Per-protocol analysis included 81 experimental and 78 control participants. Co-primary outcomes were health-related quality of life (SF-12) and peripheral artery disease -related hospitalization rate. Results. At 12 months, the experimental group showed significantly higher SF-12 Physical Component Summary (44.76 vs. 35.08; p < 0.001) and Mental Component Summary (43.42 vs. 35.90; p < 0.001) scores. Hospitalizations (14.8 % vs. 20.5 %; p = 0.346) and amputations (4.9 % vs. 7.7 %; p = 0.476) were numerically lower but did not reach statistical significance. Smoking cessation was threefold higher (25.0 % vs. 8.5 %; p = 0.026), pain declined significantly (median VAS 3 vs. 5; p < 0.001), and QALYs were higher (0.67 vs. 0.60; p < 0.001). No adverse events attributable to the program were recorded. Conclusions. The Chronic limb-threatening ischemia School significantly improved patient-reported outcomes and smoking cessation in patients with peripheral artery disease. Structured educational programs should be considered an integral component of comprehensive peripheral artery disease management.

12 October 2026 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
ACAzat Chinaliyev
Azat Chinaliyev
MOMukhammejan Orazbay
Mukhammejan Orazbay
GCGulinur Chinaliyeva
Gulinur Chinaliyeva
DKDidar Khassenov
Didar Khassenov
TSTokan Sultanaliyev
Tokan Sultanaliyev
ADAktolkyn Daumen
Aktolkyn Daumen
Background: Contemporary management of chronic post-dissection aortic disease includes open repair, thoracic endovascular aortic repair (TEVAR) with or without adjunctive false-lumen occlusion, fenestrated/branched endovascular repair, and staged open-endovascular strategies. Selection depends on anatomy, rupture risk, malperfusion, physiological reserve, and device availability. Case presentation: A 56-year-old woman with body mass index 47.2 kg/m 2 and major cardiometabolic comorbidity presented with progressive abdominal pulsation. CTA demonstrated chronic Stanford type B/DeBakey III dissection with descending thoracic aneurysmal degeneration to 52.7 mm, a dominant symptomatic infrarenal aneurysmal component measuring approximately 11–12 cm, bilateral common iliac involvement, and residual paravisceral dissection without treatment-triggering enlargement or malperfusion. No Crawford extent was assigned because complete longitudinal centerline imaging was unavailable. Stage I comprised transperitoneal open aorto-bi-iliac reconstruction. After 118 days, elective morphology-driven zone 2 TEVAR was performed to cover the reported proximal entry region and reduce antegrade false-lumen inflow. Intentional left subclavian artery (LSA) coverage without prophylactic revascularization was followed by symptomatic subclavian steal requiring unplanned carotid-subclavian bypass. Results: No perioperative death, stroke, spinal cord ischemia, bowel ischemia, myocardial infarction, acute kidney injury, graft thrombosis, prosthetic infection, or access complication occurred. At latest follow-up, the patient was asymptomatic and all reconstructions were patent. Conclusion: This case illustrates competing priorities in segment-specific management of chronic post-dissection aortic disease. The unequivocal indication for urgent infrarenal repair contrasted with discretionary pre-emptive thoracic intervention below the conventional diameter threshold. The LSA-related complication emphasizes prophylactic LSA preservation/revascularization, spinal collateral planning, and lifelong surveillance of the untreated paravisceral segment after previous abdominal aortic reconstruction.